Latest From Biotech Now

Tekmira Pharmaceuticals Ebola Drug Gets Nod From FDA

BIO Investor Forum

The U.S. Food and Drug Administration has authorized Canada’s Tekmira Pharmaceuticals to provide an experimental drug to people with confirmed or suspected Ebola virus infections, according to an article in The Wall Street Journal. “Our TKM-Ebola drug supplies are limited, but we will continue to help where we can,” Tekmira Chief Executive Mark J. Murray said in a press release. The drug is still in clinical testing to assess whether it is safe and effective. BIO Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

FierceBiotech Names 2014 Fierce 15

FierceBiotech

FierceBiotech released their much-anticipated 2014 Fierce 15 list today, their annual list of private biotech upstarts to watch. We’ll be hearing from three of them at next month’s BIO Investor Forum, October 7-8 in San Francisco: Adaptimmune and Sutro Biopharma will be making company presentations, and Editas Medicine CEO Katrine Bosley will participate as a panelist in one of our therapeutic workshops, Gene Therapy Ascending? Today’s Advancements Over Past Hurdles. Here’s the scoop on each, Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Detailed Report Examines the Crucial Role of Patents in Genetic Testing

shutterstock_27291016

In The Critical Role of Patents in the Development, Commercialization, and Utilization of Innovative Genetic Diagnostic Tests, Professor Holman argues that advocates for weakening patent protection have fundamental misconceptions on the role of patents in genetic testing. Opponents assume that patents negatively impact patient access to genetic diagnostic testing. They believe that patents inhibit research that could lead to new or improved versions of genetic tests, and that patent holders charge higher prices as exclusive Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

CFO Magazine: On the IPO On-Ramp

lab_tech

CFO Magazine highlighted the impact of the Jumpstart Our Business Startups (JOBS) Act on smaller companies aiming to obtain access to capital and the benefits of the JOBS Act by highlighting case studies from companies that went public using it. “Nearly everyone agrees that the JOBS Act has significantly affected the way IPOs are done,” writes Edward Teach. Teach talked to five companies to discuss their experiences, and not surprisingly, ‘all had strong opinions about Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

South Dakota Gov Daugaard Recieves BIO Food & Ag Award

food-and-ag-gov-of-the-year-photo

This week, BIO presented South Dakota Governor Dennis Daugaard the first ever food and agriculture Legislator of the Year Award at the 2014 Livestock Biotech Summit. When presenting the award, BIO President and CEO Jim Greenwood commented that “Governor Daugaard is a true champion of the biotechnology industry and has made investing in and promoting South Dakota’s bioeconomy a hallmark of his time in office. Washington, can learn a thing or two from Governor Daugaard’s Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,